| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14,4 M € | -3.5% | 14,9 M € | +0.8% | 14,8 M € | -1.2% | 15,0 M € | +4.1% | 14,4 M € | +16.8% | 12,3 M € | -17.5% | 14,9 M € | +0.1% | 14,9 M € | +1.0% | 14,8 M € | +1.0% | 14,6 M € | +15.4% | 12,7 M € | +1.4% | 12,5 M € | +9.8% | 11,4 M € | -0.4% | 11,4 M € | +4.2% | 11,0 M € | +18.7% | 9,2 M € | +6.5% | 8,7 M € | +1.5% | 8,5 M € | -8.6% | 9,3 M € | -3.4% | 9,7 M € | |
| EBITDA | 446,7 k € | -57.2% | 1,0 M € | -29.7% | 1,5 M € | -13.5% | 1,7 M € | +39.3% | 1,2 M € | +833.6% | -167,7 k € | -111.4% | 1,5 M € | +15.9% | 1,3 M € | -35.1% | 2,0 M € | +6.8% | 1,8 M € | +13.2% | 1,6 M € | +12.7% | 1,4 M € | +15.6% | 1,2 M € | -4.3% | 1,3 M € | +50.4% | 866,5 k € | -0.7% | 872,7 k € | +139.2% | 364,9 k € | +297.4% | -184,8 k € | -124.2% | 764,7 k € | -21.9% | 979,1 k € | |
| Operating profit | 304,3 k € | -64.8% | 863,2 k € | -33.6% | 1,3 M € | -15.6% | 1,5 M € | +50.4% | 1,0 M € | +546.5% | -229,2 k € | -118.6% | 1,2 M € | -5.7% | 1,3 M € | -14.1% | 1,5 M € | -8.9% | 1,7 M € | +13.6% | 1,5 M € | +23.0% | 1,2 M € | +9.3% | 1,1 M € | +1.3% | 1,1 M € | +59.2% | 679,2 k € | -2.7% | 697,8 k € | +317.5% | 167,1 k € | +147.4% | -352,9 k € | -153.4% | 660,5 k € | -24.7% | 877,5 k € | |
| Profit/loss | 178,4 k € | -74.7% | 706,1 k € | -34.9% | 1,1 M € | +13.7% | 954,6 k € | +8.1% | 883,0 k € | +447.7% | -254,0 k € | -124.7% | 1,0 M € | +22.2% | 842,0 k € | -16.0% | 1,0 M € | -11.9% | 1,1 M € | +12.8% | 1,0 M € | +24.7% | 808,3 k € | +10.1% | 734,0 k € | +3.3% | 710,6 k € | +53.2% | 463,9 k € | +4.5% | 444,1 k € | +211.8% | 142,4 k € | +241.8% | -100,4 k € | -129.1% | 344,5 k € | -33.1% | 514,9 k € | |
| Equity | 14,3 M € | +1.3% | 14,1 M € | +5.3% | 13,4 M € | +8.8% | 12,3 M € | +8.4% | 11,4 M € | +8.4% | 10,5 M € | -2.4% | 10,7 M € | +10.6% | 9,7 M € | +9.5% | 8,9 M € | +12.7% | 7,9 M € | +16.9% | 6,7 M € | +17.6% | 5,7 M € | +16.5% | 4,9 M € | +17.6% | 4,2 M € | +20.5% | 3,5 M € | +15.5% | 3,0 M € | +17.4% | 2,6 M € | +5.9% | 2,4 M € | -4.0% | 2,5 M € | +15.9% | 2,2 M € | |
| Total assets | 16,9 M € | +4.3% | 16,3 M € | +4.1% | 15,6 M € | +5.3% | 14,8 M € | +6.7% | 13,9 M € | +5.1% | 13,2 M € | -2.4% | 13,5 M € | +7.3% | 12,6 M € | -3.4% | 13,1 M € | +23.5% | 10,6 M € | +19.8% | 8,8 M € | +13.5% | 7,8 M € | +7.2% | 7,3 M € | -0.1% | 7,3 M € | -2.6% | 7,5 M € | +18.5% | 6,3 M € | +1.8% | 6,2 M € | -8.6% | 6,8 M € | -7.0% | 7,3 M € | -0.3% | 7,3 M € | |
| Cash | 5,1 M € | -21.5% | 6,5 M € | +18.4% | 5,5 M € | +37.0% | 4,0 M € | +74.5% | 2,3 M € | +15.3% | 2,0 M € | +11.5% | 1,8 M € | +61.0% | 1,1 M € | -14.4% | 1,3 M € | -35.5% | 2,0 M € | +1.8% | 2,0 M € | +30.4% | 1,5 M € | +177.1% | 545,4 k € | +22.0% | 447,2 k € | -16.0% | 532,6 k € | -9.6% | 589,3 k € | +2.2% | 576,6 k € | +31.1% | 439,8 k € | -32.6% | 652,9 k € | +64.7% | 396,5 k € | |
| Debts | 2,6 M € | +19.3% | 2,1 M € | -2.8% | 2,2 M € | -11.8% | 2,5 M € | -0.9% | 2,5 M € | -7.8% | 2,7 M € | -2.7% | 2,8 M € | -3.8% | 2,9 M € | -30.6% | 4,2 M € | +95.2% | 2,2 M € | +22.9% | 1,8 M € | -5.1% | 1,8 M € | -18.5% | 2,3 M € | -25.4% | 3,0 M € | -22.9% | 3,9 M € | +22.4% | 3,2 M € | -9.3% | 3,6 M € | -18.5% | 4,4 M € | -8.5% | 4,8 M € | -2.0% | 4,9 M € | |
| Staff | 21,3 | 20,4 | 20,8 | 20,8 | 23,1 | 22,8 | 21,8 | 21 | 17 | 17,4 | 17,6 | 16 | 15,6 | 15,8 | 15,4 | 14,6 | 16,3 | 14,7 | 12,6 | 13,3 | ||||||||||||||||||||
Public limited company · Aartselaar · incorporated on 17/10/1995 · 21,3 ETP
Public limited company profitable and well capitalised. Cash position declining (-21.5%).
Solid counterparty for a standard engagement.
DE CEUNYNCK MEDICAL is a Public limited company incorporated in 1995. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Aartselaar. It employs on average 21,3 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette